A hormone that triggers puberty and controls fertility in humans might be developed as a treatment for non-alcoholic fatty liver disease, according to new Rutgers research.
New research in the April 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network found the rate of mammography screenings by breast cancer survivors has […]
Researchers from Brigham and Women’s Hospital have found that administering the medication combination of mifepristone and misoprostol as early as possible can be done safely and […]
Nearly a third of pregnant Medicaid beneficiaries who have opioid use disorder and are screened for hepatitis C test positive for the potentially deadly, liver-destroying virus, […]